Effects of Celecoxib On Restenosis After Coronary Intervention and Evolution of Atherosclerosis Trial
Status:
Unknown status
Trial end date:
2009-10-01
Target enrollment:
Participant gender:
Summary
To evaluate the effect of celecoxib use for 3 month after drug-eluting stent implantation
- on restenosis
- on clinical outcome such as target lesion revascularization, thrombotic event,
myocardial infarction, death
- on inflammatory biomarkers